The biomedical device market spans three scales: nano (DNA, protein, single molecule), micro (cell, organoid, tissue), and device (implant, diagnostic instrument). Our fabrication capabilities address all three.
Multilayer PDMS chips with pneumatic Quake valves, peristaltic pumps, and thin flexible membranes replicate the microenvironment of human organs, lung, gut, kidney, brain, liver, and heart, for drug discovery and toxicity testing. PDMS soft lithography from SU-8 masters enables 3–5 day design-to-chip turnaround. COP injection-molded versions for production volumes where PDMS autofluorescence is a concern.
Planar and 3D MEA for extracellular neural signal recording, stimulation, and drug response monitoring. Pt or TiN electrode arrays on glass or Si substrate patterned by lift-off. SU-8 or polyimide passivation with electrode openings at recording sites. DRIE through-holes for 3D probe insertion. Biocompatible PI RDL for flexible implantable probe variants.
Glass flow cells with NIL-defined nanopore arrays (<50nm) for nanopore sequencing, or precision microchannels for optical sequencing. Fusion or anodic bonding for hermetic glass-glass or glass-Si seals with no adhesive in the optical path. Large-format glass processing (500×600mm) enables 96-well or 384-well array formats at low cost-per-chip, critical for sequencing instrument economics.
Localised surface plasmon resonance chips with gold nanopillar or nanohole arrays on glass, fabricated by NIL and Au lift-off. The nanostructured gold surface is functionalised with antibodies, aptamers, or nucleic acid probes for label-free detection of cancer biomarkers, pathogen proteins, and nucleic acids. Sensitivity 10–100× higher than flat Au SPR chips due to localised field enhancement.
Ni and Pd-Ni microneedle arrays by LIGA electroforming for transdermal drug delivery and interstitial fluid (ISF) sampling. Hollow microneedles with 1µm-diameter fluid channels. Droplet microfluidic chips for monodisperse microencapsulation of drug-loaded particles (CV <2%). Pd-Ni biocompatible grade for implant-contact applications.
Neural probes and implantable sensors using biocompatible PI RDL and Au/Pt electrodes. Hermetic AuSn sealing for implantable optical transceivers (retinal implants, deep brain stimulators). ISO 10993-assessed polyimide for electrode passivation. NDA-protected, your implant design remains confidential from first technical discussion.
SU-8 master on Si wafer → PDMS cast and cure → O₂ plasma bond to glass or PDMS. The fastest route from biochip design to working prototype. 3–5 days from GDS to first functional chip. Multilayer for Quake valves and 3D channel networks.
E-beam master + UV/thermal NIL for sub-50nm nanopores and Au nanostructure arrays. All : master fabrication, NIL, dry etch transfer, and Au lift-off on the same substrate.
Au, Pt, ITO, and TiN electrode deposition by PVD sputtering and evaporation. Lift-off patterning for electrode arrays with sub-5µm features. ITO for transparent electrodes in optogenetics and fluorescence biochips.
Anodic bonding (glass-Si, hermetic) and fusion bonding (glass-glass, UV-transparent) for biochip sealing. C-SAM inspection on every bond. Large-format to 500×600mm.
PC and COP chip production via injection molding, from SU-8/PDMS prototype to mass-produced polymer chip. Mold tooling fabricated . COP for low autofluorescence fluorescence assays.
Ni and Pd-Ni microneedle arrays by X-ray LIGA electroforming. 1µm hollow channel diameter. Biocompatible Pd-Ni for ISF sampling and drug delivery applications.
Panel-scale glass biochip processing produces 5–10× more chips per run versus wafer-format foundries, dramatically reducing cost-per-chip for array biosensors and diagnostic plates.
From SU-8 master fabrication to first functional PDMS chip in 3–5 days. Iterate channel geometry, valve placement, or electrode layout rapidly without waiting for minimum lot commitments.
NIL nanopore arrays for DNA sequencing, nanofluidic confinement, and molecular sieving, with master mold fabrication and pattern transfer done . No separate nanofab vendor.
ISO 10993-assessed polyimide for electrode passivation in implantable devices. Pd-Ni electroforming for biocompatible microneedles and microstructures in direct contact with biological tissue.
Prototype in PDMS, then transition to injection-molded COP with the same channel design. Mold tooling . No redesign for a different foundry process.
Biomedical device designs, assay protocols, and surface chemistry specifications are among the most sensitive in any industry. An NDA can be arranged before any design files or technical details are shared - just mention it in your first message. Initial inquiries and quotes can proceed without one.
Share your process requirements, substrate, and production volume, A Nanosystems JP Inc. engineer will respond within 1 business day. Full quote typically within 7–10 business days, subject to project complexity and NDA requirements.